1-4 of 4
Fumitaka Nagamura, MD, PhD
Close
Sort by
Journal Articles

The Immunomodulatory Effect of Triptolide on Mesenchymal Stem Cells in Vitro

Haiping He, MD PhD, Atsuko Takahashi, MT., Yuki Yamamoto, MT, Akiko Hori, Yuta Miharu, MT, Kazuaki Yokoyama, MD PhD, Miwako Narita, MD PhD, Fumitaka Nagamura, MD PhD, Arinobu Tojo, MD PhD, Tonghua Yang, MD PhD, Tokiko Nagamura-Inoue, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5011.
https://doi.org/10.1182/blood-2019-125046
Published: 2019
Journal Articles

Immunosuppressive Diversity of Umbilical Cord-Derived Mesenchymal Stromal Cells

Tokiko Nagamura-Inoue, MD PhD, Atsuko Takahashi, MT., Yuki Yamamoto, MT, Akiko Hori, Yuta Miharu, MT, Kazuo Ogami, MT, Miwako Narita, MD PhD, Fumitaka Nagamura, MD PhD, Arinobu Tojo, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3584.
https://doi.org/10.1182/blood-2019-128627
Published: 2019
Journal Articles

Comparison of the Basis for Approval and Pivotal Studies on Hematological Malignancies between the US and Japan.

Fumitaka Nagamura, MD, PhD, Tokiko Nagamura-Inoue, MD,PhD, Arinobu Tojo, MD, PhD
Journal: Blood
Blood (2006) 108 (11): 5495.
https://doi.org/10.1182/blood.V108.11.5495.5495
Published: 2006
Journal Articles

Trend of Drug Approval on Hematological Malignancies in the U.S. and Japan.

Fumitaka Nagamura, MD, PhD, Arinobu Tojo, MD, PhD, Tokiko Nagamura-Inoue, MD, PhD, Aikichi Iwamoto, MD, Phd
Journal: Blood
Blood (2005) 106 (11): 3120.
https://doi.org/10.1182/blood.V106.11.3120.3120
Published: 2005